Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| LUTEINIZING HORMONE, BETA | LUTEINIZING HORMONE, BETA. Uses: Designed for use in research and industrial production. Additional or Alternative Names: BETA-HLH;BETA-LH, HUMAN PITUITARY;BETA-LH, PORCINE PITUITARY;BETA-LH, SHEEP PITUITARY;LUTEINIZING HORMONE, BETA;LUTEINIZING HORMONE, BETA-, HUMAN PITUITARY;LUTEINIZING HORMONE, BETA-, PORCINE PITUITARY;LUTEINIZING HORMONE, BETA-, SHEEP PITUITARY. Product Category: Heterocyclic Organic Compound. Appearance: lyophilized powder. CAS No. 53664-53-2. Product ID: ACM53664532. Alfa Chemistry ISO 9001:2015 Certified. Categories: Luteinizing hormone beta polypeptide. |  |
| Luteinizing hormone (human) | Luteinizing hormone (human), a heterodimeric glycoprotein hormone produced by the pituitary gland (LH), plays key roles in human reproduction [1]. Uses: Scientific research. Group: Peptides. CAS No. 39341-83-8. Pack Sizes: 10 μg; 50 μg. Product ID: HY-P2293. |  |
| Luteinizing hormone releasingfactor | Luteinizing hormone releasingfactor. Uses: Designed for use in research and industrial production. Additional or Alternative Names: LEUTINIZING HORMONE RELEASING HORMONE;LHRH (LAMPREY III);LH-RH ACETATE;LHRH;LHRH, HUMAN;LH-RH (HUMAN) PORCINE, RAT;LH-RH LUTEINIZING HORMONE-RELEASING HORMONE;LHRH (SEA BREAM). Product Category: Heterocyclic Organic Compound. CAS No. 9034-40-6. Molecular formula: C55H75N17O13. Mole weight: 1182.29. Product ID: ACM9034406. Alfa Chemistry ISO 9001:2015 Certified. | |
| Luteinizing Hormone-Releasing Hormone (LH-RH) | Luteinizing hormone releasing hormone (LH-RH) is a reproductive hormone. Synonyms: Salmon-gnrh; Gnrh, salmon-; Salmon-LHRH; LHRH (salmon). Grades: ≥95%. CAS No. 86073-88-3. Molecular formula: C60H73N15O13. Mole weight: 1212.3. |  |
| Luteinizinghormone-releasing factor(swine),5-(3,5-diiodo-L-tyrosine)-(9ci) | Luteinizinghormone-releasing factor(swine),5-(3,5-diiodo-L-tyrosine)-(9ci). Uses: Designed for use in research and industrial production. Additional or Alternative Names: PYROGLU-HIS-TRP-SER-3,5-DIIODO-TYR-GLY-LEU-ARG-PRO-GLY-NH2;PYR-HIS-TRP-SER-3,5-DIIODO-TYR-GLY-LEU-ARG-PRO-GLY-NH2;(3,5-DIIODO-TYR5)-GONADOTROPIN-RELEASING HORMONE;(3,5-DIIODO-TYR5)-LHRH;(3,5-DIIODO-TYR5)-LUTEINIZING HORMONE-RELEASING FACTOR;(3,5-DIIODO-T. Product Category: Heterocyclic Organic Compound. CAS No. 73644-49-2. Molecular formula: C55H73I2N17O13. Mole weight: 1434.08. Purity: 0.96. IUPACName: (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxy-3,5-diiodophenyl)-1. Canonical SMILES: CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC(=C(C(=C2)I)O)I)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6. Product ID: ACM73644492. Alfa Chemistry ISO 9001:2015 Certified. | |
| Luteinizinghormone-releasing factor(swine),6-L-tryptophan- | Luteinizinghormone-releasing factor(swine),6-L-tryptophan-. Uses: Designed for use in research and industrial production. Additional or Alternative Names: (TRP6)-GONADOTROPIN-RELEASING HORMONE;(TRP6)-LHRH;(TRP6)-LUTEINIZING HORMONE-RELEASING FACTOR;(TRP6)-LUTEINIZING HORMONE-RELEASING HORMONE;(TRP6)-TRIPTORELIN;PYR-HIS-TRP-SER-TYR-TRP-LEU-ARG-PRO-GLY-NH2. Product Category: Heterocyclic Organic Compound. CAS No. 156126-74-8. Molecular formula: C64H82N18O13. Mole weight: 1311.45. Purity: 0.96. IUPACName: (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(. Canonical SMILES: CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8. Product ID: ACM156126748. Alfa Chemistry ISO 9001:2015 Certified. | |
| 2-Hydroxysaclofen | 2-Hydroxysaclofen is a potent γ-amino-butyric-acid-B (GABA B ) receptor antagonist. 2-Hydroxysaclofen can abolish nicotine-induced hypolocomotor effects and increases the antinociceptive effects. 2-Hydroxysaclofen can stimulate luteinizing hormone (LH) secretion in female rats [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 117354-64-0. Pack Sizes: 1 mg. Product ID: HY-100812. | |
| Abarelix | Abarelix is a synthetic decapeptide and antagonist of naturally occurring gonadotropin-releasing hormone (GnRH). Abarelix directly and competitively binds to and blocks the gonadotropin releasing hormone receptor in the anterior pituitary gland, thereby inhibiting the secretion and release of luteinizing hormone (LH) and follicle stimulating hormone (FSH). In males, the inhibition of LH secretion prevents the release of testosterone. As a result, this may relieve symptoms associated with prostate hypertrophy or prostate cancer, since testosterone is required to sustain prostate growth. Check for active clinical trials or closed clinical trials using this agent. Synonyms: Plenaxis, PPI-149; PPI 149; PPI149; R-3827; R 3827; R3827. Grades: 98%. CAS No. 183552-38-7. Molecular formula: C72H95ClN14O14. Mole weight: 1416.09. | |
| Alarelin acetate | Alarelin acetate is a synthetic Gonadotrophin-releasing hormone agonist. It is the acetate form of a hypothalamic peptide. It is a potent LH-RH agonist in rats and mice. It reversibly delays sexual maturation in rats, stimulates spawning activity in fish. It could inducte ovulation and is used to treat endmometriosis. It is responsible for the secretion of gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), from the pituitary glands. Uses: Alarelin acetate could inducte ovulation and is used to treat endmometriosis. it is responsible for the secretion of gonadotropins, luteinizing hormone (lh) and follicle-stimulating hormone (fsh), from the pituitary glands. Synonyms: LHRH-A; 6-D-Ala-10-D-gly-LHRH-ethylamide; Pyr-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NHEt; 6-D-Ala-10-D-gly-LHRH-ethylamide; (S)-1-((3S,6S,9S,12S,15R,18S,21S)-3-((1H-imidazol-5-yl)methyl)-6-((1H-indol-3-yl)methyl)-21-(3-((diaminomethylene)amino)propyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-18-isobutyl-15-methyl-1,4,7,10,13,16,19-heptaoxo-1-((S)-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaazadocosan-22-oyl)-N-ethylpyrrolidine-2-carboxamide diacetate. Grades: >98%. CAS No. 79561-22-1. Molecular formula: C60H86N16O16. Mole weight: 1287.42. | |
| BAY 1214784 | BAY 1214784 is a potent, selective, and orally active antagonist of the human gonadotropin-releasing hormone receptor ( hGnRH-R ). BAY 1214784 is a spiroindoline derivative compound. BAY 1214784 effectively lowers plasma luteinizing hormone levels by up to 49%, at the same time being associated with low pharmacokinetic variability and good tolerability. BAY 1214784 has the potential for the research of uterine fibroids [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1631164-25-4. Pack Sizes: 5 mg. Product ID: HY-144863. | |
| Buserelin | Buserelin is a Gonadotropin-releasing hormone agonist (GnRH agonist). The drug's effects are dependent on the frequency and time course of administration. GnRH is released in a pulsatile fashion in the postpubertal adult. Initial interaction of any GnRH agonist, such as buserelin, with the GnRH receptor induces release of FSH and LH by gonadotrophes. Synonyms: (Des-Gly10,D-Ser(tBu)6,Pro-NHEt9)-LHRH; Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHEt; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-L-arginyl-L-proline ethylamide; Bigonist; HOE-766; HOE766; HOE 766; Profact; Receptal; Suprecur; Suprefact; Tiloryth; Hoe-766 MP; D-Ser(tbu(sup 6))-LH-RH-(1-9)-nonapeptide ethylamide; (D-Ser(tbu)(sup 6)-EA(sup 10))-luteinizing hormone-releasing hormone. Grades: >98%. CAS No. 57982-77-1. Molecular formula: C60H86N16O13. Mole weight: 1239.42. | |
| Buserelin Acetate | Buserelin acetate is an imputity of Buserelin, which is a synthetic analogue of gonadotropin-releasing hormone (GnRH). It functions via binding to GnRH receptors. Buserelin is primarily used for the treatment of prostate cancer and endometriosis. Uses: Fertility agents, female. Synonyms: H-Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHEt.CH3CO2H; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-L-arginyl-L-proline ethylamide acetic acid; 6-[O-(1,1-Dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor Acetate; Estomal; Suprafact; Suprecur; Receptal; Supremon. Grades: ≥95%. CAS No. 68630-75-1. Molecular formula: C62H90N16O15. Mole weight: 1299.48. | |
| Buserelin Acetate | Gondadotropin-releasing hormone agonist, used to treat hormone-responsive cancers such as prostate and breast cancer. Synthetic nonapeptide agonist analog of LH-RH. Antineolpastic (hormonal). Group: Biochemicals. Alternative Names: 6-[O-(1,1-Dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor Monoacetate; Estomal; Suprafact; Suprecur; Supremon. Grades: Highly Purified. CAS No. 68630-75-1. Pack Sizes: 10mg. Molecular Formula: C??H??N??O??, Molecular Weight: 1299.48. US Biological Life Sciences. |  Worldwide |
| Cetrorelix | Cetrorelix is a potent gonadotrophin-releasing hormone (GnRH) antagonist. Cetrorelix inhibits the endogenous luteinizing hormone surge during ovarian stimulation. Cetrorelix reduces cyclophosphamide induced ovarian follicular destruction in mice [1] [2]. Uses: Scientific research. Group: Peptides. Alternative Names: SB-75. CAS No. 120287-85-6. Pack Sizes: 1 mg. Product ID: HY-P0009. | |
| Cetrorelix Acetate | Cetrorelix Acetate is the acetate salt of cetrorelix, which is a potent and synthetic peptide antagonist of gonadotropin-releasing hormone (GnRH) receptor antagonist with IC50 value of 1.21 nM. It binds to radioligand murine LTK- cells with Kd value of 0.2 nM. It inhibits the activation of hGnRHR and a downstream luciferase reporter gene in murine LTK- cells by the GnRHR agonist [D-Trp6]GnRH. It suppresses production of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland. It prevents ovulation during in vitro fertilization. It causes prepubertal reduction in bone density, bone strength and bone modeling. It was used as a therapeutic agent for the treatment of blood cancers such as multiple myeloma (MM). It is also used to treat hormone-sensitive cancers of the breast and prostate. It also has antidepressant and anxiolytic activity in vivo. Uses: Fertility agents, female. Synonyms: D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N5-(aminocarbonyl)-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-, acetate (1:x); D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N5-(aminocarbonyl)-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-, acetate (salt); Cetrotid; Cetrotide; D 20761; NS 75A; Ovurelix; SB 075 acetate; Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH2.CH3CO2H. Grades: >98%. CAS No. 145672-81-7. Molecular formula: C70H92ClN17O14.xC2H4O2. Mole weight: 1431.06 (free base). | |
| DCOIT | DCOIT is a representative isothiazolinone that stimulates the gonadotropin-releasing hormone receptor ( GnRHR )-mediated synthesis of follicle-stimulating hormone and luteinizing hormone in the brain. DCOIT interferes with G protein-coupled receptors, MAPK and Ca 2+ signaling cascades [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Kathon 930. CAS No. 64359-81-5. Pack Sizes: 10 mM * 1 mL; 5 g. Product ID: HY-W041308. | |
| Degarelix | Degarelix acetate is a reversible gonadotropin-releasing hormone receptor (GnRHR) antagonist. Degarelix reduces the secretion of luteinizing hormone (LH) and testosterone via blocking GnRHR. Degarelix can be used for the treatment of prostate cancer. Synonyms: Degarelix; Firmagon; FE-200486; FE 200486; FE200486; ASP-3550; ASP 3550; ASP3550; Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Phe(4-S-dihydroorotamido)-D-Phe(4-ureido)-Leu-Lys(iPr)-Pro-D-Ala-NH2. Grades: >98%. CAS No. 214766-78-6. Molecular formula: C82H103ClN18O16. Mole weight: 1632.286. | |
| Degarelix acetate hydrate | Degarelix acetate is a synthetic peptide that acts as a gonadotrophin-releasing hormone (GnRH) antagonist. Degarelix targets GnRH receptors in the pituitary gland, resulting in reduction of luteinizing hormone (LH), follicle-stimulating hormone (FSH) and suppression of testosterone. Synonyms: FE-200486; FE 200486; FE200486; ASP-3550; ASP 3550; ASP3550. CAS No. 934246-14-7. Molecular formula: C84H109ClN18O19. Mole weight: 1710.32. | |
| (Des-gly10,d-ala6,pro-nhet9)-lhrh ii(chicken) | (Des-gly10,d-ala6,pro-nhet9)-lhrh ii(chicken). Uses: Designed for use in research and industrial production. Additional or Alternative Names: (DES-GLY10,D-ALA6,PRO-NHET9)-LUTEINIZING HORMONE-RELEASING FACTOR (CHICKEN);(DES-GLY10,D-ALA6,PRO-NHET9)-LUTEINIZING HORMONE-RELEASING HORMONE (CHICKEN);(DES-GLY10,D-ALA6,PRO-NHET9)-LHRH;(DES-GLY10,D-ALA6,PRO-NHET9)-GONADOTROPIN-RELEASING HORMONE (CHICKE. Product Category: Heterocyclic Organic Compound. CAS No. 319432-42-3. Molecular formula: C61H72N16O12. Mole weight: 1139.26. Product ID: ACM319432423. Alfa Chemistry ISO 9001:2015 Certified. | |
| (Des-Gly10,D-His2,D-His(Bzl)6,Pro-NHEt9)-LHRH | Synonyms: (D-His2)-Histrelin; Pyr-D-His-Trp-Ser-Tyr-D-His(Bzl)-Leu-Arg-Pro-NHEt; L-pyroglutamyl-D-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-1-benzyl-D-histidyl-L-leucyl-L-arginyl-L-proline ethylamide; 5-Oxo-L-prolyl-D-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-1-benzyl-D-histidyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide; Luteinizing hormone-releasing factor (swine), 2-D-histidine-6-[1-(phenylmethyl)-D-histidine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide-. Grades: 95%. CAS No. 134009-10-2. Molecular formula: C66H86N18O12. Mole weight: 1323.52. | |
| (Des-Gly10,D-His2,D-Leu6,Pro-NHEt9)-LHRH | (Des-Gly10,D-His2,D-Leu6,Pro-NHEt9)-LHRH is an impurity of Leuprolide, which is a synthetic nonapeptide analog of gonadotropin-releasing hormone used as an antineoplastic agent, a gonadotropin-releasing hormone agonist, and an anti-estrogen. Synonyms: (D-His2)-Leuprolide; 2-D-Histidine-6-D-leucine-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor (swine); Leuprolide Acetate EP Impurity B; L-pyroglutamyl-D-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide; H-Pyr-D-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt; 5-Oxo-L-prolyl-D-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide. Grades: 95%. CAS No. 112642-11-2. Molecular formula: C59H84N16O12. Mole weight: 1209.40. | |
| (Des-Gly10,D-Leu6,D-Leu7,Pro-NHEt9)-LHRH | (Des-Gly10,D-Leu6,D-Leu7,Pro-NHEt9)-LHRH is an impurity of Leuprolide, which is a synthetic nonapeptide analog of gonadotropin-releasing hormone used as an antineoplastic agent, a gonadotropin-releasing hormone agonist, and an anti-estrogen. Synonyms: H-Pyr-His-Trp-Ser-Tyr-D-Leu-D-Leu-Arg-Pro-NHEt; 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-D-leucyl-L-arginyl-N-ethyl-L-prolinamide; (D-Leu7)-Leuprorelin; Leuprolide Acetate EP Impurity H; 6-D-Leucine-7-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-luteinizing hormone-releasing factor (pig); L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-D-leucyl-L-arginyl-L-proline ethylamide; D-Leu-Leuprolide; Luteinizing hormone-releasing factor (swine), 6-D-leucine-7-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-. Grades: 95%. CAS No. 112710-58-4. Molecular formula: C59H84N16O12. Mole weight: 1209.40. | |
| (Des-Gly10,Leu6,Pro-NHEt9)-LHRH | (Des-Gly10,Leu6,Pro-NHEt9)-LHRH is an impurity of Leuprolide, which is a synthetic nonapeptide analog of gonadotropin-releasing hormone used as an antineoplastic agent, a gonadotropin-releasing hormone agonist, and an anti-estrogen. Synonyms: (Leu6)-Leuprorelin; Pyr-His-Trp-Ser-Tyr-Leu-Leu-Arg-Pro-NHEt; Leuoprorelin; (L-Leu)-Leuprolide; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-L-leucyl-L-leucyl-L-arginyl-L-proline ethylamide; 6-L-Leucine-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor; 6-L-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-luteinizing Hormone-releasing Factor; Leuprolide Acetate EP Impurity C; Leuprorelin EP Impurity C; Pyr-His-Trp-Ser-Tyr-Leu-Leu-Arg-Pro-NHEt; 1-9-Luteinizing hormone-releasing factor (swine), 6-L-leucine-9-(N-ethyl-L-prolinamide)-. Grades: ≥95% by HPLC. CAS No. 54785-87-4. Molecular formula: C59H84N16O12. Mole weight: 1209.42. | |
| Deslorelin | Deslorelin is a synthetic nonapeptide analogue of the natural gonadotrophin releasing hormone super-agonist (GnRH agonist) with potential antineoplastic activity. It binds to and activates pituitary gonadotropin releasing hormone (GnRH) receptors. It stops the production of sex hormones. It is currently used to induce ovulation in mares as part of the artificial insemination process. It is also used to stabilize high-risk pregnancies, mainly of livestock and is also used to treat benign prostate hyperplasia in dogs. It is manufactured by Thorne BioScience LLC and was introduced to the USA market following the withdrawal of Ovuplant. It has been listed. Synonyms: H-Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-NHEt; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-L-leucyl-L-arginyl-L-proline ethylamide; 1-9-Luteinizing hormone-releasing factor (swine), 6-D-tryptophan-9-(N-ethyl-L-prolinamide)-; Luteinizing hormone-releasing factor (pig), 6-D-tryptophan-9-(N-ethyl-L-prolinamide)-10-deglycinamide-; D-Trp6-Pro9-N-ethylamide-LH-RH; [D-Trp6,des-Gly-NH210]-LH-RH ethylamide; [D-Trp6,des-Gly10]-LH-RH ethylamide; [D-Trp6,Pro9-NHEt]LH-RH; [de-Gly10,D-Trp6,Pro-NHEt]-LH-RH; [Des-Gly10,D-Trp6]-LH-RH ethylamide; Bachem 9022; D-Trp LHRH-PEA; H 4065; PTL 3001; Somagard; Somagorad. Grades: 98%. CAS No. 57773-65-6. Molecular formula: C64H83N17O12. Mole weight: 1282.45. | |
| Deslorelin acetate | Deslorelin acetate. Group: Biochemicals. Alternative Names: 6-D-Tryptophan-9-(N-ethyl-L-prolinamide)-1-9-luteinizing hormone-releasing factor (swine) monoacetate; Bachem 9022 acetate; D-Trp LHRH-PEA acetate. Grades: Highly Purified. CAS No. 82318-06-7. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C66H87N17O14. US Biological Life Sciences. | Worldwide |
| (D-His2)-Leuprolide Trifluoroacetic Acid Salt | (D-His2)-Leuprolide Trifluoroacetic Acid Salt. Group: Biochemicals. Alternative Names: 2-D-Histidine-6-D-leucine-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor (swine) 2,2,2-Trifluoroacetate; 2: PN: WO2009040073 PAGE: 98 claimed protein. Grades: Highly Purified. Pack Sizes: 5mg. Molecular Formula: C61H85F3N16O16, Molecular Weight: 1323.42. US Biological Life Sciences. | Worldwide |
| (D-Leu7)-LHRH | Synonyms: (D-Leu7)-Gonadorelin; Pyr-His-Trp-Ser-Tyr-Gly-D-Leu-Arg-Pro-Gly-NH2; Luteinizing hormone-releasing factor (swine), 7-D-leucine-; Luteinizing hormone-releasing factor(pig), 7-D-leucine-; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-glycyl-D-leucyl-L-arginyl-L-prolyl-glycinamide. Grades: ≥90%. CAS No. 53728-75-9. Molecular formula: C55H75N17O13. Mole weight: 1182.29. | |
| (D-Ser4)-Leuprolide Trifluoroacetic Acid Salt | (D-Ser4)-Leuprolide Trifluoroacetic Acid Salt. Group: Biochemicals. Alternative Names: 4-D-serine-6-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-luteinizing hormone-releasing Factor (pig) 2,2,2-Trifluoroacetate. Grades: Highly Purified. Pack Sizes: 5mg. Molecular Formula: C61H85F3N16O16, Molecular Weight: 1323.42. US Biological Life Sciences. | Worldwide |
| (D-Ser4)-LHRH | Synonyms: (D-Ser4)-Gonadorelin; H-Pyr-His-Trp-D-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2; L-pyroglutamyl-L-histidyl-L-tryptophyl-D-seryl-L-tyrosyl-glycyl-L-leucyl-L-arginyl-L-prolyl-glycinamide; Luteinizing hormone-releasing factor(pig), 4-D-serine-; 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-D-seryl-L-tyrosylglycyl-L-leucyl-N5-(diaminomethylene)-L-ornithyl-L-prolylglycinamide. Grades: ≥95%. CAS No. 103065-82-3. Molecular formula: C55H75N17O13. Mole weight: 1182.31. | |
| (D-Ser6,Azagly10)-LHRH | Synonyms: (D-Ser6)-Goserelin; Pyr-His-Trp-Ser-Tyr-D-Ser-Leu-Arg-Pro-Azagly-NH2; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-seryl-L-leucyl-L-arginyl-N'-carbamoyl-L-prolinehydrazide; 6-D-Serine-10-deglycinamide-2-(aminocarbonyl)hydrazide Luteinizing hormone-releasing factor (swine); Goserelin Impurity 19; 6-(des-t-Butyl-D-Serine)-Goserelin; 5-Oxo-L-prolyl-L-histidyl-N-[(1S,4S,7R,10S,13S)-18-amino-13-({(2S)-2-[(2-carbamoylhydrazino)carbonyl]-1-pyrrolidinyl}carbonyl)-4-(4-hydroxybenzyl)-1,7-bis(hydroxymethyl)-18-imino-10-isobutyl-2,5,8,11-tetraoxo-3,6,9,12,17-pentaazaoctadec-1-yl]-L-tryptophanamide. Grades: 95%. CAS No. 65807-03-6. Molecular formula: C55H76N18O14. Mole weight: 1213.30. | |
| (D-Trp6)-LHRH free acid | (D-Trp6)-LHRH free acid is a luteinizing hormone-releasing hormone ( LHRH ) agonist [1]. Uses: Scientific research. Group: Peptides. CAS No. 129418-54-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P4572. | |
| D-Trp-Leuprolide | D-Trp-Leuprolide is an impurity of Leuprolide, which is a synthetic nonapeptide analog of gonadotropin-releasing hormone used as an antineoplastic agent, a gonadotropin-releasing hormone agonist, and an anti-estrogen. Synonyms: 5-Oxo-L-prolyl-L-histidyl-D-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide; Pyr-His-D-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt; (S)-N-ethyl-1-(((S)-5-oxopyrrolidine-2-carbonyl)-L-histidyl-D-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl)pyrrolidine-2-carboxamide; L-Prolinamide, 5-oxo-L-prolyl-L-histidyl-D-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-; 1-9-Luteinizing hormone-releasing factor (swine), 3-D-tryptophan-6-D-leucine-9-(N-ethyl-L-prolinamide)-; Leuprorelin EP Impurity E. Grades: ≥95%. CAS No. 1926163-23-6. Molecular formula: C59H84N16O12. Mole weight: 1209.42. | |
| (D-Tyr5)-Leuprolide Trifluoroacetic Acid Salt | (D-Tyr5)-Leuprolide Trifluoroacetic Acid Salt. Group: Biochemicals. Alternative Names: 5-D-Tyrosine-6-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-luteinizing hormone-releasing Factor (swine) 2,2,2-Trifluoroacetate. Grades: Highly Purified. Pack Sizes: 5mg. Molecular Formula: C61H85F3N16O16, Molecular Weight: 1323.42. US Biological Life Sciences. | Worldwide |
| Fertirelin | Fertirelin. Uses: Designed for use in research and industrial production. Additional or Alternative Names: PYR-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-NHET;PYROGLU-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO NHCH2CH3;PGLU-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-NHET;FERTIRELIN;GLP-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-NHET;[DES-GLY10] LH-RH, ETHYL AMIDE;[DES-GLY10] LUTEINIZING HORMONE-RELEASI. Product Category: Heterocyclic Organic Compound. CAS No. 38234-21-8. Molecular formula: C55H76N16O12. Mole weight: 1153.29. Purity: >98%. Density: 1.49 g/cm³. Product ID: ACM38234218. Alfa Chemistry ISO 9001:2015 Certified. | |
| Fulvestrant | Fulvestrant is a selective estrogen receptor degrader (SERD) that downregulates and degrades estrogen receptor α (ERα).1,2 It binds to rat uterine ER with an IC50 value of 44.8nM and prevents uterine weight increases induced by estradiol in immature rats (ED50> = 0.06mg/kg per day) but has no effect on uterine weight alone.3 It also decreases uterine weight in adult rats without affecting the production of luteinizing and follicle-stimulating hormones and prolactin. Fulvestrant inhibits the growth of ER-positive MCF-7 human breast cancer cells but not ER-negative BT-20 cells when used at a concentration of 1ug/ml. It also prevents tumor growth in MCF-7 and Br10 breast cancer mouse xenograft models when used at a single dose of 5mg per animal. Fulvestrant is neuroprotective in vitro against neurotoxicity induced by glutamate- and amyloid- β (1-42) (A β42) in primary rat hippocampal cells.4 Formulations containing fulvestrant have been used in the treatment of estro Group: Biochemicals. Alternative Names: (7α,17 β ) -7-[9-[4, 4, 5, 5, 5-Pentafluoropentyl) sulfinyl]nonyl]estra-1, 3, 5 (10) -triene-3, 17-diol; Faslodex; Fulvestrant; ICI 182780; ZD 182780; ZD 9238; ZM 182780. Grades: Highly Purified. CAS No. 129453-61-8. Pack Sizes: 50mg, 100mg. Molecular Formula: C??H??F?O?S, Molecular Weight: 606.77. US Biological Life Sciences. | Worldwide |
| Glycinamide ribonucleotide | Glycineamide ribonucleotide (or GAR) is an intermediate in de novo purine biosynthesis. It is formed from phosphoribosylamine by the enzyme phosphoribosylamine-glycine ligase. In the next step of purine biosynthesis the enzyme phosphoribosylglycinamide formyltransferase acts on GAR to form FGAR. GAR formation is stimulated by Luteinizing hormone (LH) and Chorionic gonadotropin (HCG) via activation of Glc-6-P-dehydrogenase. Synonyms: 5'-Phosphoribosylglycinamide; N1-(5-Phospho-D-ribosyl)glycinamide; [(2R,3S,4R,5R)-5-[(2-aminoacetyl)amino]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate; n-glycyl-5-o-phosphono-|A-d-ribofuranosylamine; 5'-phosphoribosylglycinamide; GAR; N1-(5-Phospho-D-ribosyl)glycinamide; N1-(5-phospho-beta-D-ribosyl)glycinamide. CAS No. 10074-18-7. Molecular formula: C7H15N2O8P. Mole weight: 286.18. | |
| GnRH-I | GnRH-I, a small 10 amino acid long peptide (decapeptide) from the hypothalamus, has previously been demonstrated and shown to be biologically active in the immune system, notably within T cells and acts at the hypophysis to cause an increase in release of biologically active Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) in the blood. Synonyms: Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2; Luliberin; LH-Releasing hormone; AY-24031; AY 24031; AY24031; Relisorm L; Synthetic gonadoliberin; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-glycyl-L-leucyl-L-arginyl-L-prolyl-glycinamide. Grades: ≥98%. Molecular formula: C55H75N17O13. Mole weight: 1182.29. | |
| Gonadorelin acetate | Gonadorelin acetate. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Cystorelin, Lutrepulse, Fertiline, Lutrelef, Luprolite acetate, Gonadorelin acetate, CID11980076, LS-88221, Luteinizing hormone-releasing factor (pig), acetate (salt), Synthetic luteinizing hormone-releasing factor acetate, Luteinizing hormone-releasing factor (swine), acetate (salt), 34973-08-5, 66036-44-0. Product Category: Heterocyclic Organic Compound. CAS No. 66036-44-0. Molecular formula: C55H75N17O13. Mole weight: 1242.342060 [g/mol]. Purity: 0.96. IUPACName: acetic acid; (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxyphenyl). Canonical SMILES: CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O. Product ID: ACM66036440. Alfa Chemistry ISO 9001:2015 Certified. | |
| Gonadorelin Acetate | Gonadorelin a synthetic decapeptide prepared for gonadotropin-releasing hormone (GnRH), affects follicle stimulating hormones. Uses: Use in reproduction medicine diagnosis of the hypothalamic-pituitary-gonadal axis function cryptorchism. Synonyms: Luteinizing hormone-releasing factor (swine), acetate (1:x); Luteinizing hormone-releasing factor (pig), acetate (salt); Luteinizing hormone-releasing factor (swine), acetate (salt); 16: PN: WO2006018418 SEQID: 12 claimed protein; Cystorelin; Fertiline; Luprolite acetate; Lutrelef; Lutrepulse; Synthetic luteinizing hormone-releasing factor acetate. Grades: >98%. CAS No. 34973-08-5. Molecular formula: C55H75N17O13.xC2H4O2. Mole weight: 1182.29 (free base). | |
| Gonadorelin diacetate | Gonadorelin diacetate is the acetate form of Gonadorelin. Gonadorelin, a synthetic decapeptide prepared using solid phase peptide synthesis, is another name for gonadotropin-releasing hormone (GnRH) for evaluating the functional capacity and response of the gonadotropes of the anterior pituitary also for evaluating residual gonadotropic function of the pituitary following removal of a pituitary tumor by surgery and/or irradiation. Synonyms: Luteinizing hormone releasing hormone (human) (porcine, rat) diacetate; gonadotropin-releasing hormone (porcine, rat) diacetate; gnrh (porcine, rat) diacetate; LH-RH (human) (porcine, rat) diacetate; H-Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2.2CH3CO2H; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-glycyl-L-leucyl-L-arginyl-L-prolyl-glycinamide acetic acid. Grades: 98%. CAS No. 71447-49-9. Molecular formula: C55H75N17O13.2(C2H4O2). Mole weight: 1302.41. | |
| Gonadorelin Hydrochloride | Gonadorelin is a synthetic decapeptide prepared by solid-phase peptide synthesis. It is used to assess the functional ability and response of gonadotropin in the anterior pituitary gland, as well as after pituitary resection. It is mainly used for cows to estrus at the same time to treat abnormal ovarian function. Synonyms: Luteinizing hormone-releasing factor (swine), hydrochloride (1:x); Luteinizing hormone-releasing factor (pig), hydrochloride; Factrel; Gonadorelin hydrochloride; LH-RH hydrochloride; Gonadorelin HCl; H-Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2.xHCl; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-glycyl-L-leucyl-L-arginyl-L-prolyl-glycinamide hydrochloride. Grades: 95%. CAS No. 51952-41-1. Molecular formula: C55H75N17O13.xHCl. Mole weight: 1182.29 (free base). | |
| Gonadorelin monoacetate | Gonadorelin monoacetate is an exogenous peptide formulated for application in studying hormone-responsive ailments encompassing prostate cancer, breast cancer and ovarian cancer. Synonyms: Luteinizing hormone-releasing factor (swine), monoacetate; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-glycyl-L-leucyl-L-arginyl-L-prolyl-glycinamide acetic acid; H-Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2.CH3CO2H; Dirigestran monoacetate; Dirigestran Spofa monoacetate; Fertagyl monoacetate; Follicle-stimulating hormone-releasing factor (pig) monoacetate; Godorel monoacetate; Gonadorelin monoacetate; Gonadotropin-releasing factor monoacetate. CAS No. 499785-55-6. Molecular formula: C55H75N17O13.C2H4O2. Mole weight: 1242.34. | |
| Goserelin Acetate | Goserelin Acetate. Group: Biochemicals. Alternative Names: 6-[O-(1,1-Dimethylethyl)-D-serine]-1-9-luteinizing Hormone-releasing Factor (swine) 2- (Aminocarbonyl) hydrazide Acetate; Fertilan;D-Ser(But)6Azgly10-gonadorelin. Grades: Highly Purified. CAS No. 145781-92-6. Pack Sizes: 5mg, 10mg, 25mg. Molecular Formula: C??H??N??O??; x C?H?O?, Molecular Weight: 1269.41. US Biological Life Sciences. | Worldwide |
| Goserelin Acetate | Goserelin is a synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH) with antineoplastic activity. Goserelin binds to and activates pituitary gonadotropin releasing hormone (GnRH) receptors. Uses: Antineoplastic agents, hormonal. Synonyms: (D-Ser(tBu)6,Azagly10)-LHRH Acetate; Zoladex; 6-[O-(1,1-Dimethylethyl)-D-serine]-1-9-luteinizing Hormone-releasing Factor (swine) 2-(Aminocarbonyl)hydrazide Acetate; Fertilan; Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH2.CH3CO2H; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-L-arginyl-N'-carbamoyl-L-prolinehydrazide acetic acid. Grades: 98%. CAS No. 145781-92-6. Molecular formula: C61H88N18O16. Mole weight: 1329.49. | |
| Goserelin Acetate | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standardsbuilding blocks. Alternative Names: 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-, 2-(aminocarbonyl)hydrazide, acetate (1:?),Goserelin Acetate, Fertilan, 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-, 2-(aminocarbonyl)hydrazide, acetate (salt) (9CI), Luteinizing hormone-releasing factor (pig), 6-[O-(1,1-dimethylethyl)-D-serine]-10-deglycinamide-, 2-(aminocarbonyl)hydrazide, acetate (salt). |  |
| Goserelin Acteate | N-(21-((1H-indol-3-yl)methyl)-1,1-diamino-12-(tert-butoxymethyl)-6-(2-(2-carbamoylhydrazinecarbonyl)cyclopentanecarbonyl)-15-(4-hydroxybenzyl)-18-(hydroxymethyl)-25-(1H-imidazol-5-yl)-9-isobutyl-8,11,14,17,20,23-hexaoxo-2,7,10,13,16,19,22-heptaazapentacos-1-en-24-yl)-5-oxopyrrolidine-2-carboxamide Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH2. injectable gonadotropin releasing hormone superagonist (GnRH agonist) or luteinizing hormone antiproliferative activity in breast, prostate and endometrial cancers. CAS No. 145781-92-6. Product ID: 1-01628. Molecular formula: C59H84N18O14. Mole weight: 1269.42. Purity: 0.99. Properties: water soluble. Categories: Goserelin acetate. |  |
| Histrelin | Histrelin is a nonapeptide analog of GnRH (gonadotropin-releasing hormone) with added potency. When present in the bloodstream, it can act on gonadotropes. Histrelin can stimulate these cells to release luteinizing hormone and follicle-stimulating hormone. Histrelin is considered a GnRH agonist. It can be used for the treatment of menstruation disorders. Uses: Menstruation disorders. Synonyms: Histrelinum; ORF 17070. Grades: 98%. CAS No. 76712-82-8. Molecular formula: C66H86N18O12. Mole weight: 1323.5. | |
| Histrelin acetate | An acetate salt obtained by combining histrelin with acetic acid. The amount of acetic acid present can vary and a variable amount of water may be present. Histrelin acetate is used as a subcutaneous hydrogel implant for the treatment of prostate cancer and for the suppression of gonadal sex hormone production in children with central precocious puberty. Synonyms: 1-9-Luteinizing hormone-releasing factor (swine), 6-[1-(phenylmethyl)-D-histidine]-9-(N-ethyl-L-prolinamide)-, acetate (1:x); 1-9-Luteinizing hormone-releasing factor (swine), 6-[1-(phenylmethyl)-D-histidine]-9-(N-ethyl-L-prolinamide)-, acetate (salt); Supprelin; H-Pyr-His-Trp-Ser-Tyr-D-His(1-Bn)-Leu-Arg-Pro-NHEt.xCH3CO2H; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-1-benzyl-D-histidyl-L-leucyl-L-arginyl-L-proline ethylamide acetic acid. Grades: >98%. CAS No. 220810-26-4. Molecular formula: C66H86N18O12.xC2H4O2. Mole weight: 1323.50 (free base). | |
| H-Ser-tyr-gly-leu-arg-pro-gly-nh2 | H-Ser-tyr-gly-leu-arg-pro-gly-nh2. Uses: Designed for use in research and industrial production. Additional or Alternative Names: LH-RH Fragment 4-10, Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2, Luteinizing hormone releasing hormone Fragment 4-10, AC1N71DH, SureCN11884805, L5387_SIGMA, 1-[2-[[2-[[2-[[2-[(2-amino-3-hydroxypropanoyl)amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide, 51776-33-1. Product Category: Heterocyclic Organic Compound. CAS No. 51776-33-1. Molecular formula: C33H53N11O9. Mole weight: 747.84. Purity: 0.96. IUPACName: 1-[2-[[2-[[2-[[2-[(2-amino-3-hydroxypropanoyl)amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide. Canonical SMILES: CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)N. Product ID: ACM51776331. Alfa Chemistry ISO 9001:2015 Certified. | |
| Kisspeptin 10 (dog) | Kisspeptin 10 (dog) is an endogenous ligand for the canine KISS1 receptor. It stimulates section of follicle stimulating hormone, estradiol and luteinizing hormone in vivo. Molecular formula: C65H87N17O14. Mole weight: 1330.51. | |
| Lecirelin acetate | Lecirelin acetate, a synthetic gonadotropin-releasing hormone (GnRH) analogue, has a good effect in the treatment of bovine ovarian follicular cysts. It is a medication commonly used in veterinary. Synonyms: Luteinizing hormone-releasing factor (pig), 6-(3-methyl-D-valine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-, acetate; Dalmarelin acetate; Gestran acetate; Gestran Plus acetate; Supergestran acetate; H-Pyr-His-Trp-Ser-Tyr-D-Gly(tBu)-Leu-Arg-Pro-NHEt.CH3CO2H; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-2-tert-butyl-D-glycyl-L-leucyl-L-arginyl-L-proline ethylamide acetic acid. Grades: ≥95%. Molecular formula: C61H88N16O14. Mole weight: 1269.45. | |
| Leuprolide Acetate | Synthetic nonapeptide agonist analog of LH-RH. Antineoplastic (hormonal). Group: Biochemicals. Alternative Names: 6-D-Leucine-9- (N-ethyl-L-prolinamide ) -10-deglycinamide luteinizing Hormone-Releasing Factor Acetate(Pig); A 43818; Abbott 43818; Leuprorelin Acetate; Lupron; Procren Depot; Procrin; Prostap; TAP 144; TAP 144SR. Grades: Highly Purified. CAS No. 74381-53-6. Pack Sizes: 10mg, 25mg. Molecular Formula: C??H??N??O??, Molecular Weight: 1269.45. US Biological Life Sciences. | Worldwide |
| Leuprolide Acetate EP Impurity E | Leuprolide Acetate EP Impurity E. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: Leuprolide Acetate EP Impurity E, 1-9-Luteinizing hormone-releasing factor (swine), 3-D-tryptophan-6-D-leucine-9-(N-ethyl-L-prolinamide)-,L-Prolinamide, 5-oxo-L-prolyl-L-histidyl-D-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-. CAS No. 1926163-23-6. IUPAC Name: (2S)-N-[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide. Molecular formula: C59H84N16O12. Mole weight: 1209.40. Catalog: APS1926163236. SMILES: CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6. Format: Neat. | |
| Leuprolide Acetate EP Impurity H | Leuprolide Acetate EP Impurity H. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: Leuprolide Acetate EP Impurity H,Luteinizing hormone-releasing factor (swine), 6-D-leucine-7-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide- (9CI), Luteinizing hormone-releasing factor (pig), 6-D-leucine-7-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-. CAS No. 112710-58-4. IUPAC Name: (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(2S)-5-carbamimidamido-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide. Molecular formula: C59H84N16O12. Mole weight: 1209.40. Catalog: APS112710584. SMILES: CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@H](Cc5c[nH]cn5)NC(=O)[C@@H]6CCC(=O)N6. Format: Neat. | |
| Leuprolide impurity (1-8) | Leuprolide impurity (1-8) is an impurity of Leuprolide, which is a synthetic nonapeptide analog of gonadotropin-releasing hormone used as an antineoplastic agent, a gonadotropin-releasing hormone agonist, and an anti-estrogen. Synonyms: Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg; 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-Seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginine; LHRH (1-8); 1-8-Luteinizing hormone-releasing factor (swine), 6-D-leucine-; Luteinizing hormone-releasing factor (pig), 6-D-leucine-9-de-L-proline-10-deglycinamide-; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginine. Grades: ≥95% by HPLC. CAS No. 112642-14-5. Molecular formula: C52H72N14O12. Mole weight: 1085.23. | |
| LGnRH-III, lamprey acetate | LGnRH-III, lamprey acetate, a GnRH isoform isolated from the sea lamprey, is a weak GnRH receptor agonist with anti-tumor activity. It is an evolutionarily conserved member of the GnRH family and can stimulate the secretion of gonadotropins, luteinizing, and follicle-stimulating hormones. Synonyms: H-Pyr-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH2.CH3CO2H; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-histidyl-L-alpha-aspartyl-L-tryptophyl-L-lysyl-L-prolyl-glycinamide acetate. Grades: ≥95%. Molecular formula: C61H78N18O16. Mole weight: 1319.38. | |
| Lhrh(1-6)(free acid) | Lhrh(1-6)(free acid). Uses: Designed for use in research and industrial production. Additional or Alternative Names: PYR-HIS-TRP-SER-TYR-GLY-OH TRIFLUOROACETATE SALT;LUTEINIZING HORMONE-RELEASING HORMONE (1-6) TRIFLUOROACETATE SALT;LUTEINIZING HORMONE-RELEASING FACTOR (1-6) TRIFLUOROACETATE SALT;GONADOTROPIN-RELEASING HORMONE (1-6) TRIFLUOROACETATE SALT;LHRH (1-6) TRIF. Product Category: Heterocyclic Organic Compound. CAS No. 103067-73-8. Molecular formula: C36H41N9O10. Mole weight: 873.79. Product ID: ACM103067738. Alfa Chemistry ISO 9001:2015 Certified. Categories: LHRH (1-6) (free acid). | |
| LHRH (chicken) | It is a luteinizing hormone-releasing hormone (LHRH) that stimulates the anterior pituitary to release gonadotropins, thereby regulating reproductive function. Synonyms: H-Pyr-His-Trp-Ser-Tyr-Gly-Leu-Gln-Pro-Gly-NH2; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-glycyl-L-leucyl-L-glutaminyl-L-prolyl-glycinamide; [Gln8]-C517 (LH-RH), chicken; 8-Glutamine-LHRH; GNRH, Chicken I; 8-Gln-LHRH; LHRH-I; pGlu-His-Trp-Ser-Tyr-Gly-Leu-Gln-Pro-Gly-NH2. Grades: 95%. CAS No. 47922-48-5. Molecular formula: C54H71N15O14. Mole weight: 1154.23. | |
| LHRH free acid | LHRH (free acid), the luteinizing hormone-releasing hormone, is a neuropeptide hypothalamic. LHRH regulates reproduction. LHRH can be used for the research of cancer [1]. Uses: Scientific research. Group: Peptides. CAS No. 35263-73-1. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P4675. | |
| LHRH II | LHRH II, first found in chicken, is highly conserved in vertebrates. Synonyms: LH-RH II, chicken; Pyr-His-Trp-Ser-His-Gly-Trp-Tyr-Pro-Gly-NH2; LHRH, His(5)-Trp(7)-Tyr(8)-; Glycinamide, 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-histidylglycyl-L-tryptophyl-L-tyrosyl-L-prolyl-; 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-histidylglycyl-L-tryptophyl-L-tyrosyl-L-prolylglycinamide; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-histidyl-glycyl-L-tryptophyl-L-tyrosyl-L-prolyl-glycinamide; GNRH, Chicken II; pGlu-His-Trp-Ser-His-Gly-Trp-Tyr-Pro-Gly-NH2; 5-Histidyl-7-tryptophyl-8-tyrosine-LHRH; Luteinizing hormone-releasing factor II (chicken); cGnRH II. Grades: ≥95%. CAS No. 91097-16-4. Molecular formula: C60H69N17O13. Mole weight: 1236.32. | |
| Nafarelin | Synthetic gonadotropin-releasing hormone (GnRH) agonist that stimulates secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Repeated administration causes desensitization of pituitary GnRH receptors resulting in inhibition of gonadotropin release and decreased steroid hormone synthesis. Synonyms: H-Pyr-His-Trp-Ser-Tyr-D-2Nal-Leu-Arg-Pro-Gly-NH2. Grades: 98%. CAS No. 76932-56-4. Molecular formula: C66H83N17O13. Mole weight: 1322.47. | |
| Nafarelin acetate | Nafarelin acetate. Uses: Designed for use in research and industrial production. Additional or Alternative Names: NAFARELIN ACETATE;(6-D-(2-Naphthyl)alanine)lhrh acetate;(6-D-(2-Naphthyl)alanine)luteinizing hormone-releasing hormone acetate;Luteinizing hormone-releasing factor (pig), 6-(3-(2-naphthalenyl)-D-alanine)-, monoacetate (salt);Luteinizing hormone-releasing. Product Category: Heterocyclic Organic Compound. CAS No. 78115-72-7. Molecular formula: C68H87N17O15. Mole weight: 1382.52. Product ID: ACM78115727. Alfa Chemistry ISO 9001:2015 Certified. | |
| Nafarelin Acetate | Nafarelin is a GnRH (gonadotropin-releasing hormone) agonist used for the treatment of precocious puberty in children and Premature LG surges. Synonyms: Luteinizing hormone-releasing factor (swine), 6-[3-(2-naphthalenyl)-D-alanine]-, acetate (1:x); Luteinizing hormone-releasing factor (pig), 6-[3-(2-naphthalenyl)-D-alanine]-, acetate (salt); Luteinizing hormone-releasing factor (swine), 6-[3-(2-naphthalenyl)-D-alanine]-, acetate (salt); Nafarelin acetate; Synarel; Synarela; H-Pyr-His-Trp-Ser-Tyr-D-2Nal-Leu-Arg-Pro-Gly-NH2.CH3CO2H; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-3-(2-naphthyl)-D-alanyl-L-leucyl-L-arginyl-L-prolyl-glycinamide acetic acid. Grades: ≥95%. CAS No. 76932-60-0. Molecular formula: C66H83N17O13.xC2H4O2. Mole weight: 1322.47 (free base). | |
| Nafarelin Acetate Hydrate (1:x:x) | Nafarelin, under the brand name Synarel, is a gonadotropin-releasing hormone (GnRH) agonist. It can decrease pituitary secretion of the gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Nafarelin is used in women for the treatment of endometriosis that decreases the abnormal tissue and relieves the symptoms. Uses: The treatment of endometriosis. Synonyms: 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-3-(2-naphthyl)-D-alanyl-L-leucyl-L-arginyl-L-prolylglycinamide acetate salt hydrate. CAS No. 86220-42-0. Molecular formula: C66H83N17O13.xC2H4O2.xH2O. Mole weight: 1400.5. | |
| Nafarelin monoacetate | Nafarelin is a GnRH (gonadotropin-releasing hormone) agonist. Its proposed mechanism of action is the desensitization of pituitary gonadotropin-releasing hormone receptors leading to a decrease in gonadotropin release, and ovarian hormone serum concentrations similar to those achieved in postmenopausal women. It can decrease pituitary secretion of the gonadotropins LH and FSH. Nafarelin can be used for the treatment of precocious puberty in chirldren and Premature LG surges. Synonyms: Luteinizing hormone-releasing factor (swine), 6-[3-(2-naphthalenyl)-D-alanine]-, monoacetate (salt); H-Pyr-His-Trp-Ser-Tyr-D-2Nal-Leu-Arg-Pro-Gly-NH2.CH3CO2H; L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-3-(2-naphthyl)-D-alanyl-L-leucyl-L-arginyl-L-prolyl-glycinamide acetic acid. Grades: 95%. CAS No. 263878-43-9. Molecular formula: C66H83N17O13.C2H4O2. Mole weight: 1382.53. | |
| Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline | A luteinizing hormone releasing hormone (LHRH). Molecular formula: C26H35N8O18P2. Mole weight: 809.55. | |
| (O-Acetyl-L-Ser)-Leuprolide | (O-Acetyl-L-Ser)-Leuprolide is an impurity of Leuprolide, which is a synthetic nonapeptide analog of gonadotropin-releasing hormone used as an antineoplastic agent, a gonadotropin-releasing hormone agonist, and an anti-estrogen. Synonyms: 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl(Ac)-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide; 1-9-Luteinizing hormone-releasing factor (swine), 4-(O-acetyl-L-serine)-6-D-leucine-9-(N-ethyl-L-prolinamide)-; Pyr-His-Trp-Ser(Ac)-Tyr-Leu-Leu-Arg-Pro-NHEt; Ser(Ac)-Leuprolide; L-Prolinamide, 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-O-acetyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-; L-pyroglutamyl-L-histidyl-L-tryptophyl-O-acetyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide; Leuprolide Acetate EP Impurity D; Leuprolide Impurity D. Grades: ≥95%. CAS No. 1926163-25-8. Molecular formula: C61H86N16O13. Mole weight: 1251.46. | |
| Ozarelix | Ozarelix is a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors. Mechanistically, LHRH antagonists exert rapid inhibition of luteinizing hormone and follicle stimulating hormone with an accompanying rapid decrease in sex hormones and would therefore be expected to be effective in a variety of hormonally dependent disease states including ovarian cancer, prostate cancer, BPH, infertility, uterine myoma and endometriosis. BPH is a non-cancerous enlargement of the prostate that is caused by testosterone. Unlike LHRH agonists, ozarelix has the potential to reduce testosterone just enough to reduce both prostate size and symptoms without the severe side effects associated with a reduction in testosterone. Synonyms: D 63153; D-63 153; D-63153; D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-N6-(aminocarbonyl)-D-lysyl-L-norleucyl-L-arginyl-L-prolyl-. CAS No. 295350-45-7. Molecular formula: C72H96ClN17O14. Mole weight: 1459.11. | |
| pyroglutamyl-peptidase II | Highly specific for thyrotropin releasing hormone (pyroglutamyl-histidyl-prolylamide). Will not cleave the pyroglutamyl-histidyl bond of luteinizing hormone releasing hormone. Found in serum and brain. Inhibited by metal chelators. In peptidase family M1 (membrane alanyl aminopeptidase family). Group: Enzymes. Synonyms: thyroliberinase; pyroglutamyl aminopeptidase II; thyrotropin-releasing factor pyroglutamate aminopeptidase; pyroglutamate aminopeptidase II; pyroglutamyl peptidase II; thyroliberin-hydrolyzing pyroglutamate aminopeptidase; thyrotropin-releasing hormone-degrading pyroglutamate aminopeptidase; thyrotropin-releasing hormone-degrading peptidase; TRH aminopeptidase. Enzyme Commission Number: EC 3.4.19.6. CAS No. 60063-88-9. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4090; pyroglutamyl-peptidase II; EC 3.4.19.6; 60063-88-9; thyroliberinase; pyroglutamyl aminopeptidase II; thyrotropin-releasing factor pyroglutamate aminopeptidase; pyroglutamate aminopeptidase II; pyroglutamyl peptidase II; thyroliberin-hydrolyzing pyroglutamate aminopeptidase; thyrotropin-releasing hormone-degrading pyroglutamate aminopeptidase; thyrotropin-releasing hormone-degrading peptidase; TRH aminopeptidase. Cat No: EXWM-4090. |  |
| Relugolix | Relugolix, also known as TAK-385, is a luteinizing hormone-releasing hormone (LH-RH) receptor antagonist administered orally. By preventing LH-RH from binding with the LH-RH receptor in the anterior pituitary gland and suppressing the secretion of luteinizing hormone (LH) and follicle stimulation hormone (FSH) from the anterior pituitary gland, TAK-385 controls the effect of LH and FSH on the ovary, reduces the level of estrogen in blood, which is known to be associated with the development of endometriosis and uterine fibroids, and is expected to improve the symptoms of these disorders. Uses: Androgen antagonists. Synonyms: TAK-385; N-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-N'-methoxyurea; Orgovyx; RVT 601; 1-{4-[1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea. Grades: ≥95%. CAS No. 737789-87-6. Molecular formula: C29H27F2N7O5S. Mole weight: 623.63. | |
Our database is helping our users find suppliers everyday.
